A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 35/28 (2006.01) A61K 35/00 (2006.01) A61K 35/14 (2006.01)
Patent
CA 2430937
A process of decreasing the expression of one or more of the inflammatory cytokines IFN-y and IL-6 from cells in a mammalian patient, comprises administering to the patient an effective amount of stressed mammalian blood cells, said stressed cells having been extracorporeally subjected to at least one stressor selected from oxidative stress and ultraviolet radiation. These findings are indicative of the use of the process in the treatment for alleviation of chronic fatigue syndrome.
L'invention concerne un procédé permettant de diminuer l'expression d'une ou de plusieurs cytokines IFN-.gamma. et IL-6 de cellules chez un patient mammifère, et qui consiste à administrer au patient une quantité pharmaceutiquement efficace de cellules sanguines mammifères stressées, ces cellules ayant été soumises de manière extra-corporelle à au moins un agresseur sélectionné parmi le stress oxydant et le rayonnement ultraviolet. Le procédé peut s'utiliser pour alléger le syndrome de fatigue chronique.
Bolton Anthony Ernest
Mandel Arkady
Sauder Daniel Nathan
Ridout & Maybee Llp
Vasogen Ireland Limited
LandOfFree
Inflammatory cytokine secretion inhibition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inflammatory cytokine secretion inhibition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inflammatory cytokine secretion inhibition will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2036977